Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report) shares dropped 2% on Tuesday . The company traded as low as C$2.36 and last traded at C$2.41. Approximately 48,885 shares traded hands during mid-day trading, a decline of 65% from the average daily volume of 141,018 shares. The stock had previously closed at C$2.46.
Cardiol Therapeutics Trading Down 3.3 %
The business’s 50 day moving average price is C$2.20 and its two-hundred day moving average price is C$1.58. The company has a current ratio of 5.29, a quick ratio of 6.84 and a debt-to-equity ratio of 0.52. The company has a market capitalization of C$152.36 million, a price-to-earnings ratio of -5.47 and a beta of 0.75.
About Cardiol Therapeutics
Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis.
See Also
- Five stocks we like better than Cardiol Therapeutics
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Comprehensive PepsiCo Stock Analysis
- What is the Dogs of the Dow Strategy? Overview and Examples
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Bear Market Funds to Watch This Year
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
